Financial statements Hecpharma
Balance sheet data of HECPHARMA
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|---|
| Total assets | 730 473,28 | 3 534 212,43 | 3 157 999,28 | 4 482 177,14 | 6 010 003,39 | 6 241 786,24 | 6 486 392,85 |
| A. Fixed assets | 128 914,69 | 390 763,58 | 421 035,85 | 412 427,92 | 2 171 539,60 | 2 677 090,19 | 2 795 724,80 |
| B. Current assets | 601 558,59 | 3 143 448,85 | 2 736 963,43 | 4 069 749,22 | 3 838 463,79 | 3 564 696,05 | 3 690 668,05 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 730 473,28 | 3 534 212,43 | 3 157 999,28 | 4 482 177,14 | 6 010 003,39 | 6 241 788,24 | 6 486 392,85 |
| A. Equity | 3 644,90 | 1 079 281,21 | 2 442 029,40 | 3 497 465,34 | 5 104 509,59 | 5 484 504,47 | 5 523 724,34 |
| B. Liabilities and provisions for liabilities | 726 828,38 | 2 454 931,22 | 715 969,88 | 984 711,80 | 905 493,80 | 757 281,77 | 962 668,51 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| II. Short-term liabilities | 655 645,32 | 2 144 020,53 | 687 938,76 | 980 671,98 | 905 493,80 | 757 281,77 | 616 616,84 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.